Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years.
Want more time for what matters most? MyCase streamlines your firm so you can focus on winning cases. See how much time you could save with our Law Firm Time Savings Calculator—try it now!
It's an impossibly complex web of moral turpitude out there in corporate America.
Consider how much better we'd be doing than China on AI, and everything else, if our population as a whole could dramatically out-think China's.
The designer will remain as Global Ambassador on Sustainability at the French fashion company.
This is easier to implement than you might think.
From training to technology, uncover the essential steps to futureproof your law firm in a competitive market.
If you’re looking for a completely unique viewpoint on law firm management, well, you’ve found it.
The vast majority who try to time the market fail.
China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is booming as well as therapeutic areas where he sees promising science.
The first thing Americans are getting fleeced on is the $TRUMP memecoin.
How to make the right decision, and why there might be another way to shape a fulfilling legal career on your own terms.
Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 million. The company has plans to go public 'at some point,' but it isn’t in any hurry, said CEO Abhinav Shashank.
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.
Buried amid all the gift-wrapped underwear and hideous sweaters, we might find one or two things we will enjoy.
Until someone issues refunds or gets a court judgment, what can investors do to minimize their losses?
A greasy form of chemistry still exists between the two.